Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Fossati

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
La Radiologia Medica|October 23, 2016
Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) surveyGiulia Marvaso, Barbara Vischioni, Barbara Alicja Jereczek-Fossa, et al.
Cancers|December 30, 2020
Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY)Slavisa Tubin, Seema Gupta, Michael Grusch, et al.
Frontiers in Oncology|September 2, 2022
Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomesMaciej J Pelak, Birgit Flechl, Eugen Hug, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2023
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in AustraliaVerity Ahern, Sebastian Adeberg, Piero Fossati, et al.
Cancers|December 28, 2019
Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical OutcomesKyungdon Choi, Silvia Molinelli, Stefania Russo, et al.
BMC Cancer|September 16, 2019
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm studyViviana Vitolo, Lorenzo Cobianchi, Silvia Brugnatelli, et al.
Radiation Oncology (London, England)|July 26, 2012
Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-frameworkKerstin A Kessel, Nina Bougatf, Christian Bohn, et al.
BMC Cancer|April 5, 2012
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trialStephanie E Combs, Meinhard Kieser, Daniel Habermehl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2022
The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapyCarola Lütgendorf-Caucig, Maciej Pelak, Birgit Flechl, et al.
Journal of Applied Clinical Medical Physics|September 30, 2016
MRI quantification of pancreas motion as a function of patient setup for particle therapy -a preliminary studyGiulia Fontana, Marco Riboldi, Chiara Gianoli, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
La Radiologia Medica|October 23, 2016
Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) surveyGiulia Marvaso, Barbara Vischioni, Barbara Alicja Jereczek-Fossa, et al.
Cancers|December 30, 2020
Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY)Slavisa Tubin, Seema Gupta, Michael Grusch, et al.
Frontiers in Oncology|September 2, 2022
Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomesMaciej J Pelak, Birgit Flechl, Eugen Hug, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2023
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in AustraliaVerity Ahern, Sebastian Adeberg, Piero Fossati, et al.
Cancers|December 28, 2019
Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical OutcomesKyungdon Choi, Silvia Molinelli, Stefania Russo, et al.
BMC Cancer|September 16, 2019
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm studyViviana Vitolo, Lorenzo Cobianchi, Silvia Brugnatelli, et al.
Radiation Oncology (London, England)|July 26, 2012
Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-frameworkKerstin A Kessel, Nina Bougatf, Christian Bohn, et al.
BMC Cancer|April 5, 2012
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trialStephanie E Combs, Meinhard Kieser, Daniel Habermehl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2022
The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapyCarola Lütgendorf-Caucig, Maciej Pelak, Birgit Flechl, et al.
Journal of Applied Clinical Medical Physics|September 30, 2016
MRI quantification of pancreas motion as a function of patient setup for particle therapy -a preliminary studyGiulia Fontana, Marco Riboldi, Chiara Gianoli, et al.
Pageof 9